01099.HK
Sinopharm Group Co. Ltd.
HKSE · Healthcare · Medical - Distribution · CN
HKD 15.02
−0.07%Year over year
Reported trailing growth
- Revenue
- -1.4%
- EBITDA
- -0.0%
- EBIT
- +10.9%
- EPS
- +3.2%
- Free cash flow
- +177.5%
- Operating cash flow
- +150.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +1.4%
- EBITDA
- -9.8%
- EBIT
- -8.0%
- Net income
- -5.7%
- EPS
- -5.7%
- Free cash flow
- -12.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026